Increased class A scavenger receptor and glomerular lipid precede mesangial matrix expansion in the bGH mouse model

Growth Hormone and IGF Research

Volumn 20, Issue 4, 2010, Pages 326-332

  Doi, Sonia Q ^a   Chilakamarri, Geetha C ^a,b   Mendonca, Maria C ^a   Araujo, Magali ^a   Nguyen, Nga ^c   Zuhl, Irina ^c   List, Edward O ^d   Kopchick, John J ^d   Hirata, Mario H ^e   Sellitti, Donald F ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d OHIO UNIVERSITY   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glomerulosclerosis; Kidney; Macrophage; Mesangial cells; Mouse

Indexed keywords

ABC TRANSPORTER A1; ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; IMMUNOFLUORESCENCE; KIDNEY CORTEX; KIDNEY SCAR; LIPID STORAGE; MACROPHAGE; MALE; MESANGIUM CELL; MICROALBUMINURIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GLOMERULAR MESANGIUM; GROWTH HORMONE; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY GLOMERULUS; LIPID METABOLISM; LIPIDS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A;

EID: 77955422850     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.05.002     Document Type: Article

References (33)

1. Diamond J.R. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int. Suppl. 1991, 39:S29-S34.
2. Moorhead J.F. Lipids and progressive kidney disease. Kidney Int. Suppl. 1991, 39:S35-S40.
3. Kim S.B., Kang S.A., Cho Y.J., Park S.K., Cheong H.I., Lee J.D., Hong C.D., Park J.S. Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 1994, 67:327-333.
4. Nishida Y., Oda H., Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. Suppl. 1999, 56:S51-S53.
5. Wheeler D.C., Persaud J.W., Fernando R., Sweny P., Varghese Z., Moorhead J.F. Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol. Dial. Transplant. 1990, 5:185-191.
6. Lee H.S., Kim Y.S. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int. 1998, 54:848-856.
7. Magil A.B., Frohlich J.J., Innis S.M., Steinbrecher U.P. Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int. 1993, 43:1243-1250.
8. Rayner H.C., Ward L., Walls J. Cholesterol feeding following unilateral nephrectomy in the rat leads to glomerular hypertrophy. Nephron 1991, 57:453-459.
9. Machado M.O., Hirata R.D., Sellitti D.F., Iotti R., Iotti A., Cusumano A.M., Riordan G.P., Coschigano K.T., Kopchick J.J., Zuhl I., Nguyen N., Hirata M.H., Doi S.Q. Growth hormone promotes glomerular lipid accumulation in bGH mice. Kidney Int. 2005, 68:2019-2028.
10. Doi S.Q., Rasaiah S., Tack I., Mysore J., Kopchick J.J., Moore J., Hirszel P., Striker L.J., Striker G.E. Low-protein diet suppresses serum insulin-like growth factor-1 and decelerates the progression of growth hormone-induced glomerulosclerosis. Am. J. Nephrol. 2001, 21:331-339.
11. Minto A.W., Fogel M.A., Natori Y., O'Meara Y.M., Abrahamson D.R., Smith B., Salant D.J. Expression of type I collagen mRNA in glomeruli of rats with passive Heymann nephritis. Kidney Int. 1993, 43:121-127.
12. Yagi M., Yamamoto T., Nagano N., Kato S., Kusaka M., Kawasaki K., Yaoita E., Kihara I. Transient expression of type I collagen in glomeruli with anti-Thy-1 antibody-induced mesangial proliferative lesions. Pathol. Int. 1995, 45:409-414.
13. Cramp D.G., Moorhead J.F., Wills M.R. Disorders of blood-lipids in renal disease. Lancet 1975, 1:672-673.
14. Grone H., Walli A., Grone E., Niedmann P., Thiery J., Seidel D., Helmchen U. Induction of glomerulosclerosis by dietary lipids: a functional and morphologic study in the rat. Lab. Invest. 1989, 60:433-446.
15. Abrass C.K. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am. J. Nephrol. 2004, 24:46-53.
16. Kume S., Uzu T., Araki S., Sugimoto T., Isshiki K., Chin-Kanasaki M., Sakaguchi M., Kubota N., Terauchi Y., Kadowaki T., Haneda M., Kashiwagi A., Koya D. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 2007, 18:2715-2723.
17. Frick F., Bohlooly-Y M., Lindén D., Olsson B., Törnell J., Edén S., Oscarsson J. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1230-E1239.
18. Olsson B., Bohlooly-Y M., Brusehed O., Isaksson O.G.P., Ahren B., Olofsson S., Oscarsson J., Tornell J. Bovine growth homone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E504-E511.
19. Yang C., Striker L.J., Pesce C., Chen W.Y., Peten E.P., Elliot S., Doi R., Kopchick J.J., Striker G.E. Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice. Lab. Invest. 1993, 68:62-70.
20. Quaife C.J., Mathews L.S., Pinkert C.A., Hammer R.E., Brinster R.L., Palmiter R.D. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989, 124:40-48.
21. Vijayakumar A., Novosyadlyy R., Wu Y., Yakar S., LeRoith D. Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 2010, 20:1-7.
22. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 1999, 257:29-33.
23. Ruan X.Z., Moorhead J.F., Fernando R., Wheeler D.C., Powis S.H., Varghese Z. Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem. Soc. Trans. 2004, 32:88-91.
24. Kim H.J., Moradi H., Yuan J., Norris K., Vaziri N.D. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009, 296:F1297-F1306.
25. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am. J. Kidney Dis. 1993, 22:72-82.
26. Berfield A.K., Chait A., Oram J.F., Zager R.A., Johnson A.C., Abrass C.K. IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride. Am. J. Physiol. Renal Physiol. 2006, 290:F138-F147.
27. Ruan X.Z., Varghese Z., Powis S.H., Moorhead J.F. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int. 1999, 56:440-451.
28. Takemura T., Yoshioka K., Aya N., Murakami K., Matumoto A., Itakura H., Kodama T., Suzuki H., Maki S. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int. 1993, 43:918-927.
29. Alpers C.E., Hudkins K.L., Gown A.M., Johnson R.J. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int. 1992, 41:1134-1142.
30. Floege J., Johnson R.J., Couser W.G. Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin. Invest. 1992, 70:857-864.
31. Reddy G.R., Pushpanathan M.J., Ransom R.F., Holzman L.B., Brosius F.C., Diakonova M., Mathieson P., Saleem M.A., List E.O., Kopchick J.J., Frank S.J., Menon R.K. Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology 2007, 148:2045-2055.
32. Bariety J., Nochy D., Mandet C., Jacquot C., Glotz D., Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int. 1998, 53:918-925.
33. Fornoni A., Ijaz A., Tejada T., Lenz O. Role of inflammation in diabetic nephropathy. Curr. Diabetes Rev. 2008, 4:10-17.